A Phase II Study Designed to Evaluate the Value of Alkagin Paste in the Prevention of Radiation Dermatitis for Patients Undergoing External Radiation Therapy
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Maximum skin toxicity
The objective of this study is to determine the occurrence and degree of acute skin toxicity in patients receiving radical radiation therapy with preventive application of Alkagin Paste compared to patients treated with institutional standard skin care.
7 weeks post beginning of radiation treatments
Yes
Te Vuong, MD
Principal Investigator
Jewish General Hospital
Canada: Research Ethics Office
11-052
NCT01408407
December 2011
December 2014
Name | Location |
---|